COPD Diagnosis and Individualized Selection of Treatments and Devices: A Path to Better Outcomes
 
Release Date: October 11, 2019
Last Reviewed: October 6, 2019
Expiration Date: October 11, 2020
Time to Complete Activity: 1.5 hours
 
Faculty
Sandra G. Adams, MD, MS (Chair)
Professor of Medicine
Division of Pulmonary Diseases and Critical Care Medicine
UT Health San Antonio
South Texas Veterans Health Care System
San Antonio, TX
President/CEO/Board Member
WipeDiseases™ Foundation
 
Steering Committee
Ramon G. Reyes, MD

Diplomate, American Board of Family Practice
Family Practice Specialist
Bandera Family Medical Group
San Antonio, TX
 
Brian W. Carlin, MD
Sleep Medicine and Lung Health Consultants
Pittsburgh Critical Care Associates
Pittsburgh, PA
 
This activity is jointly provided by Paradigm Medical Communications, LLC and WipeDiseases™ Foundation.  
                                                                                                                 
 
Program Description
The nonspecific symptoms and heterogeneous presentations of chronic obstructive pulmonary disease (COPD) make this common condition notoriously difficult to diagnose and treat. Yet without recognition and proper therapy, patients are susceptible to preventable COPD-related exacerbations, hospitalizations, and death. Using a novel, interactive, video-centered, case-based approach, this expert-led live web activity will familiarize family physicians (FPs) with practical, guideline-recommended tools they can use to confidently make a diagnosis of COPD and to select an individualized treatment plan that fosters adherence and meets patients’ needs.
 
Target Audience
This activity has been designed to address the educational needs of FPs. It may also benefit other healthcare professionals (HCPs) engaged or interested in the care of patients with COPD, including internists, pulmonologists, nurse practitioners (NPs), and PAs.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
• Accurately diagnose patients with COPD based on a thorough evaluation using tests and tools as outlined by current best practice guideline recommendations
• Formulate evidence-based treatment plans for patients with COPD based on symptom severity and exacerbation risk
• Match patients to an appropriate device from among the inhalers and nebulizers available for COPD treatment based on their individual characteristics, including technique needed for proper actuation and use
 
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Paradigm Medical Communications, LLC and WipeDiseases™ Foundation. Paradigm Medical Communications, LLC is accredited by the ACCME to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
PA Continuing Education
PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 
Disclosure of Commercial Support
This program is supported in part by independent education grants from AstraZeneca Pharmaceuticals LP; Mylan Specialty L.P. and Theravance Biopharma US, Inc; and Sunovion Pharmaceuticals Inc.
 
Instructions for Participation
To receive a CME certificate of participation, you should:
• Follow instructions to register or log in with your professional information and complete the preactivity assessment
• View the online activity in its entirety
• Complete and submit the online posttest and evaluation
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
 
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
 
There is no fee required for participation in this activity.
 
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
 
Browsers and Mobile Apps for Viewing Published Courses:
Windows: Internet Explorer 11, Microsoft Edge (latest version), Google Chrome (latest version), Firefox (latest version)
Mac: Safari (latest version), Google Chrome (latest version), Firefox (latest version)
Mobile: Safari in Apple iOS 10 or later, Google Chrome in Apple iOS 10 or later, Google Chrome in Android OS 4.4 or later
 
Required Browser Settings for Viewing Published Courses
JavaScript must be enabled for published courses to work.
Font downloads must be enabled to see the correct fonts and characters.
 
Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.
 
Disclosures
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty
Sandra G. Adams, MD, MS

Grant/Research Support: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; Sunovion Pharmaceuticals, Inc
 
Steering Committee
Ramon G. Reyes, MD

No financial relationships to disclose.
 
Brian W. Carlin, MD
Retained Consultant: GlaxoSmithKline; Monaghan Medical Corporation; Mylan Laboratories Inc.; Philips Respironics; Sunovion Pharmaceuticals Inc; Theravance Biopharma, Inc.
Speakers Bureau: GlaxoSmithKline, Monaghan Medical Corporation; Mylan Laboratories Inc.; Philips Respironics; Sunovion Pharmaceuticals Inc
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
 
Independent peer reviewer has no financial relationships to disclose.
 
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration (FDA).
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or WipeDiseases™ Foundation. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC or WipeDiseases™ Foundation. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC or WipeDiseases™ Foundation. Paradigm Medical Communications, LLC and WipeDiseases™ Foundation accept no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC and WipeDiseases™ Foundation are committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC and WipeDiseases™ Foundation to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC and WipeDiseases™ Foundation do not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC and WipeDiseases™ Foundation will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC and WipeDiseases™ Foundation staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2019 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.